This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
Drug Development

China's Challenges and Opportunities in the Wake of COVID-19

Posted by on 17 July 2020
Share this article
Discover how pharma companies in China are collaborating like never before to keep the supply chain from breaking, as well as asking the government to help address a flurry of issues laid bare by the public health crisis. Insights into these pressing issues and much more are detailed in the newly released China’s Challenges and Opportunities in the Wake of COVID-19 by Pharma Intelligence.

Download Now -  SPECIAL REPORT: 2019 Biopharma Outlook Facing an Uncertain Future

What’s Inside:
  • Rare peek into the policies behind the vaccines race
  • How China reacted to the deficiencies in primary healthcare exposed by COVID-19
  • The impact COVID-19 has had on pharmaceutical supply chains
  • How telecare and telemedicine are valued more than ever

ChinaBio_Partnering_Forum_Digital_Banners_900x100 (002)

Share this article

Sign up for Partnering, Business Development & Licensing email updates